Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The lung cancer mutation consortium experience

作者: Lynette M Sholl , Dara L Aisner , Marileila Varella-Garcia , Lynne D Berry , Dora Dias-Santagata

DOI: 10.1097/JTO.0000000000000516

关键词:

摘要: … Molecular genetic analyses of lung adenocarcinoma have recently become standard of care for treatment selection. The Lung Cancer Mutation Consortium was formed to enable …

参考文章(41)
Robert C. Doebele, Xian Lu, Christopher Sumey, DeLee A. Maxson, Andrew J. Weickhardt, Ana B. Oton, Paul A. Bunn, Anna E. Barón, Wilbur A. Franklin, Dara L. Aisner, Marileila Varella-Garcia, D. Ross Camidge, Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer Cancer. ,vol. 118, pp. 4502- 4511 ,(2012) , 10.1002/CNCR.27409
Lynette M. Sholl, Stanislawa Weremowicz, Stacy W. Gray, Kwok-Kin Wong, Lucian R. Chirieac, Neal I. Lindeman, Jason L. Hornick, Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK- Rearranged Lung Adenocarcinomas Journal of Thoracic Oncology. ,vol. 8, pp. 322- 328 ,(2013) , 10.1097/JTO.0B013E31827DB604
Edward S Kim, Roy S Herbst, Ignacio I Wistuba, J Jack Lee, George R Blumenschein Jr, Anne Tsao, David J Stewart, Marshall E Hicks, Jeremy Erasmus Jr, Sanjay Gupta, Christine M Alden, Suyu Liu, Ximing Tang, Fadlo R Khuri, Hai T Tran, Bruce E Johnson, John V Heymach, Li Mao, Frank Fossella, Merrill S Kies, Vassiliki Papadimitrakopoulou, Suzanne E Davis, Scott M Lippman, Waun K Hong, None, The BATTLE Trial: Personalizing Therapy for Lung Cancer Cancer Discovery. ,vol. 1, pp. 44- 53 ,(2011) , 10.1158/2159-8274.CD-10-0010
Marcel Wiesweg, Saskia Ting, Henning Reis, Karl Worm, Stefan Kasper, Mitra Tewes, Anja Welt, Heike Richly, Johannes Meiler, Sebastian Bauer, Jörg Hense, Thomas C. Gauler, Jens Köhler, Wilfried E. Eberhardt, Kaid Darwiche, Lutz Freitag, Georgios Stamatis, Frank Breitenbücher, Jeremias Wohlschlaeger, Dirk Theegarten, Cordula Derks, Diana Cortes-Incio, Gabriele Linden, Silke Skottky, Peter Lütkes, Alexander Dechêne, Andreas Paul, Peter Markus, Kurt W. Schmid, Martin Schuler, Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center European Journal of Cancer. ,vol. 49, pp. 3076- 3082 ,(2013) , 10.1016/J.EJCA.2013.06.014
Aaron S. Mansfield, William R. Sukov, Jeanette E. Eckel-Passow, Yuta Sakai, Frank J. Walsh, Melissa Lonzo, Anne E. Wiktor, Ahmet Dogan, Robert B. Jenkins, Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of her2 status in breast cancer American Journal of Clinical Pathology. ,vol. 139, pp. 144- 150 ,(2013) , 10.1309/AJCP13GJAOJAYJMW
Jeffrey A. Engelman, Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nature Reviews Cancer. ,vol. 9, pp. 550- 562 ,(2009) , 10.1038/NRC2664
Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Journal of Thoracic Oncology. ,vol. 8, pp. 823- 859 ,(2013) , 10.1097/JTO.0B013E318290868F
L. V. Sequist, B. A. Waltman, D. Dias-Santagata, S. Digumarthy, A. B. Turke, P. Fidias, K. Bergethon, A. T. Shaw, S. Gettinger, A. K. Cosper, S. Akhavanfard, R. S. Heist, J. Temel, J. G. Christensen, J. C. Wain, T. J. Lynch, K. Vernovsky, E. J. Mark, M. Lanuti, A. J. Iafrate, M. Mino-Kenudson, J. A. Engelman, Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002003
Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, Linea C Melchior, Charlotte K Rask, Junia C Costa, Birgit G Skov, Jens Benn Sørensen, Eric Santoni-Rugiu, Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report. BMC Research Notes. ,vol. 6, pp. 489- 489 ,(2013) , 10.1186/1756-0500-6-489
Chenguang Li, Rong Fang, Yihua Sun, Xiangkun Han, Fei Li, Bin Gao, A. John Iafrate, Xin-Yuan Liu, William Pao, Haiquan Chen, Hongbin Ji, Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers PLoS ONE. ,vol. 6, pp. e28204- ,(2011) , 10.1371/JOURNAL.PONE.0028204